Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia
- 1 June 2001
- Vol. 57 (6), 1073-1077
- https://doi.org/10.1016/s0090-4295(01)00985-2
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasterideUrology, 2000
- Prostate Volume and Serum Prostate–Specific Antigen as Predictors of Acute Urinary RetentionEuropean Urology, 2000
- Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasiaUrology, 1999
- Long-Term Effects of Finasteride in Patients with Benign Prostatic Hyperplasia: A Double-Blind, Placebo-Controlled, Multicenter StudyUrology, 1998
- The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1998
- Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasiaUrology, 1997
- Can finasteride reverse the progress of benign prostatic hyperplasia? a two-year placebo-controlled studyUrology, 1995
- Finasteride (MK‐906) in the treatment of benign prostatic hyperplasiaThe Prostate, 1993
- The Effect of Finasteride in Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1992
- The Clinical Effects of a 5α-Reductase Inhibitor, Finasteride, on Benign Prostatic HyperplasiaJournal of Urology, 1992